Diseases Articles A-Z

How Is Mono Spread? - Leprosy Transmission

This page contains links to eMedTV Diseases Articles containing information on subjects from How Is Mono Spread? to Leprosy Transmission. The information is organized alphabetically; the "Favorite Articles" contains the top articles on this page. Links in the box will take you directly to the articles; those same links are available with a short description further down the page.
Favorite Articles
Descriptions of Articles
  • How Is SARS Spread?
    This eMedTV segment explains that SARS is spread through the air or by touching an infected surface. This article discusses how the virus that causes this disease is transmitted and provides a detailed description of what qualifies as close contact.
  • How Leprosy Spreads
    Factors discussed in this eMedTV article that may influence how leprosy spreads include genetics, the degree of susceptibility, and the extent of exposure. This article also looks at the likelihood of transmitting leprosy to household contacts.
  • Ilara
    Ilaris helps reduce inflammation in people with cryopyrin-associated periodic syndromes (CAPS). This eMedTV page takes a look at this prescription medicine, including how it is given and what else it is used for. Ilara is a common misspelling of Ilaris.
  • Ilaris
    Ilaris is used to treat cryopyrin-associated periodic syndromes, which are rare inflammatory conditions. This eMedTV article contains details on what else this medicine is used for, how it works, dosing instructions, possible side effects, and more.
  • Ilaris and Breastfeeding
    No research has been done to determine if Ilaris (canakinumab) passes through human breast milk. This eMedTV page explains why it may not be safe to receive Ilaris while breastfeeding and covers what to discuss with your doctor before using this drug.
  • Ilaris and Pregnancy
    This eMedTV Web page takes a look at whether Ilaris (canakinumab) is safe for use during pregnancy. This article explains how this drug may cause delays in fetal bone development and discusses when a pregnant woman might receive Ilaris.
  • Ilaris and Uveitis
    This eMedTV article explains that if you have certain inflammatory conditions, Ilaris can help reduce symptoms like conjunctivitis and uveitis. An overview of Ilaris and how it works to treat rare genetic conditions is discussed in this article.
  • Ilaris Dosage
    The guidelines for Ilaris dosing are based on a person's weight, age, and other factors. This page of the eMedTV site examines these and other factors your doctor will consider when determining your dose and explains what to expect while using this drug.
  • Ilaris Drug Interactions
    Live vaccinations, echinacea, and various other drugs may cause negative interactions with Ilaris. This eMedTV Web selection takes an in-depth look at other products that may cause potentially serious problems and explains how to avoid them.
  • Ilaris Medication Information
    This eMedTV page covers basic information on Ilaris, a medication prescribed to treat a group of rare conditions that cause inflammation in the body. This article explains how the drug works and how it is given. A link to more details is also included.
  • Ilaris Overdose
    This eMedTV segment explains that if you overdose on Ilaris (canakinumab), it can cause problems like headaches and nausea. This article lists other potential overdose symptoms that may occur and describes possible treatment options.
  • Ilaris Side Effects
    Some of the potential Ilaris side effects include coughing, headaches, and a runny nose. This eMedTV segment provides a detailed list of other possible reactions to this medication, including serious problems that may require medical treatment.
  • Ilaris Uses
    As this eMedTV resource explains, Ilaris is used for the treatment of systemic juvenile idiopathic arthritis, as well as certain other conditions. This page takes an in-depth look at what this drug is used for and explains how it works.
  • Ilaris Warnings and Precautions
    You may not be able to safely use Ilaris if you have hepatitis or HIV. This page of the eMedTV Web site takes an in-depth look at important precautions and safety warnings for Ilaris, with details on potentially serious problems that may occur.
  • Ilaro
    As this eMedTV resource explains, people who have certain inflammatory conditions may benefit from Ilaris. This page gives an overview of this drug, including dosing tips and potential side effects. Ilaro is a common misspelling of Ilaris.
  • Ileri
    As explained in this eMedTV resource, Ilaris is prescribed to reduce inflammation caused by cryopyrin-associated periodic syndromes (CAPS). This page takes a quick look at this drug and its uses. Ileri is a common misspelling of Ilaris.
  • Infant Botulism
    The most common type of botulism is infant botulism, which accounts for 75 percent of all cases each year. This eMedTV segment explains this condition in detail, including causes, symptoms, treatments, and prognosis, and more.
  • Influensa
    Influenza is a highly contagious respiratory infection. This eMedTV Web page describes some of the complications associated with influenza and explains how the disease is spread from person to person. Influensa is a common misspelling of influenza.
  • Influenza
    An estimated 10 to 20 percent of Americans come down with influenza, or the flu, each year. This eMedTV page covers this highly contagious respiratory infection, including how it is transmitted, who is at risk, and how it's different from a cold.
  • Influenza Information
    Are you looking for information on influenza? This selection from the eMedTV Web site has details on this topic, including how influenza (the flu) is spread, how it differs from the common cold, and more.
  • Influenza Vaccine
    The influenza vaccine is usually given through an injection, but a new nasal spray has recently been approved by the FDA. This eMedTV resource explains how the influenza vaccine is created, who should get it, and possible side effects.
  • Influenzae
    Influenza is a viral infection of the respiratory system. This page on the eMedTV site lists common symptoms of the disease and explains how influenza viruses are transmitted from person to person. Influenzae is a common misspelling of influenza.
  • Information about Raynaud's
    This selection from the eMedTV site features some basic information about Raynaud's phenomenon, a condition that results in reduced blood supply to the extremities. This article looks at causes, symptoms, treatment, and more.
  • Information About Scleroderma
    Scleroderma is a condition that is three times more likely to occur in women than in men. This eMedTV article gives an overview of scleroderma, with information about symptoms, who is most commonly affected, and more.
  • Information on Leprosy
    This section from the eMedTV archives presents some basic information on leprosy. It explains that there are different kinds of leprosy, which means symptoms and treatment vary from person to person. There is also a link for those who want to learn more.
  • Information on Typhoid Fever
    This eMedTV selection gives some basic information on typhoid fever, a condition that is caused by bacteria. This article explores the symptoms, transmission, and treatment of this disease, with a link to learn more.
  • Infulenza
    Influenza outbreaks usually occur in the late fall and winter. This eMedTV resource lists common symptoms of influenza, describes how the viral infection is spread, and explains how it can be prevented. Infulenza is a common misspelling of influenza.
  • Is Leprosy Contagious?
    Evidence indicates that leprosy is contagious only when a person has not received treatment. As this eMedTV segment explains, once treatment has begun, a person shortly becomes noninfectious. This article also includes a link to more detailed information.
  • Is SARS Contagious?
    Is SARS contagious? Yes -- the SARS virus is very contagious. As this eMedTV article explains, it is spread through person-to-person contact, either through the air or by touching a contaminated surface. This segment talks about SARS transmission.
  • Leporsy
    Leprosy is a disease that may be the most common cause of crippling of the hands. This eMedTV article lists possible risk factors for leprosy and explains how the disease is thought to be transmitted. Leporsy is a common misspelling of leprosy.
  • Lepresse
    Leprosy is an infectious disease that usually affects the skin and peripheral nerves. This eMedTV segment explains how the condition may be spread and describes various treatment options that are available. Lepresse is a common misspelling of leprosy.
  • Leprocy
    Leprosy is an infectious disease caused by a bacterial infection. This eMedTV Web page explores how this disease may be spread, lists possible symptoms, and explains what treatments are available. Leprocy is a common misspelling of leprosy.
  • Leprosy
    Leprosy is a complex infectious disease caused by an infection with the bacteria Mycobacterium leprae. This eMedTV article discusses the disease in detail, including its history, transmission methods, the various types, treatments, and prevalence.
  • Leprosy -- American Statistics
    According to this eMedTV page, each year in the United States, there are 200 to 250 new cases of leprosy. American statistics on the disease show that the largest numbers of cases are in California, Texas, and Florida, and affect mostly immigrants.
  • Leprosy Diagnosis
    This eMedTV article explains the process doctors use to make a leprosy diagnosis. For example, the doctor begins with a physical exam and questions about the patient's medical history. If needed, a skin biopsy is performed to check for the bacteria.
  • Leprosy Disease
    This page of the eMedTV site takes a look at the disease leprosy, which is a contagious bacterial infection. This segment discusses its effects in the body, the different types, and treatment options, with a link to learn more.
  • Leprosy Facts
    This eMedTV resource presents some important facts on leprosy, a disease that has long been misunderstood -- and possibly even misidentified. This page explores different aspects of leprosy and links to more information.
  • Leprosy in the United States
    There are 200 to 250 new reported cases of leprosy in the United States each year. This eMedTV page explains how 175 of these are cases diagnosed for the first time. The page also lists the states and populations where the disease is often found.
  • Leprosy Information
    If you are looking for information on leprosy, this eMedTV segment is a great place to start. It discusses one possible transmission method and how the disease is treated, with a link to a full-length article on this topic.
  • Leprosy Skin Lesions
    This eMedTV article discusses leprosy skin lesions in detail for both types of the disease. For example, slightly red patches of skin that appear on the trunk or extremities, or a symmetrical skin rash are two possible indications of leprosy.
  • Leprosy Statistics
    This eMedTV article offers a variety of leprosy statistics, both worldwide and in the United States. For example, there are approximately 6,500 U.S. cases of leprosy, and the disease is more common in tropical areas, like South America.
  • Leprosy Symptoms
    About three to five years after becoming infected with the bacteria that cause leprosy, symptoms begin. This eMedTV article discusses these symptoms in detail for the two types of leprosy and explains why they can vary.
  • Leprosy Transmission
    Most scientists believe that leprosy transmission occurs from person to person in respiratory droplets. This eMedTV article discusses these and other factors that may influence the spread of disease, such as genetic factors.
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.